(Q35569055)

8 August 2017

title

Soft steroids: a new approach to the treatment of inflammatory airways diseases (English)

1 reference

8 August 2017

1

Maria G Belvisi

1 reference

8 August 2017

2

David J Hele

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14580922

25 March 2024

publication date

1 January 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1094553903001056?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1094-5539(03)00105-6

https://api.elsevier.com/content/article/PII:S1094553903001056?httpAccept=text/plain

25 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1094-5539(03)00105-6

Pulmonary Pharmacology & Therapeutics

25 March 2024

published in

1 reference

8 August 2017

volume

16

1 reference

8 August 2017

issue

6

1 reference

8 August 2017

page(s)

321-325

1 reference

Anti-inflammatory actions of glucocorticoids: molecular mechanisms

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Mechanisms involved in the side effects of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Soft drug design: general principles and recent applications

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

New biologically active pregnan-21-oic acid esters

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Rapid metabolic inactivation of tipredane, a structurally novel topical steroid

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Efficacy and tolerance of fluocortin butyl administered twice daily in adult patients with perennial rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Double-blind trials of inhaled beclomethasone diproprionate and fluocortin butyl ester in allergen-induced immediate and late asthmatic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Therapeutic strategies for allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

1 reference

7 January 2021

Loteprednol etabonate: a soft steroid for the treatment of allergic diseases of the airways

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Recent advances in retrometabolic design approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Novel therapies for the treatment of inflammatory airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2803%2900105-6

7 January 2021

Drug therapy in asthma bronchiale in the new millennium

series ordinal

25

1 reference

https://api.crossref.org/works/10.1016/S1094-5539(03)00105-6

25 March 2024

Identifiers

1 reference

release_spnfzafievd5np7rku6rloo4aa

8 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/spnfzafievd5np7rku6rloo4aa

24 November 2022

mapped directly with Wikidata item

1 reference